Connect with us

Hi, what are you looking for?

Health Care Sector

New Joint Venture IncuBIO to Attract Venture Capital

IncuBIO-Cuba
IncuBio S.A. to attract financing for early stage proof-of-concept clinical trials of new biotech and pharmaceutical products. Photo: Chokniti Khongchum

A new joint venture company, IncuBio S.A., has been established in the Mariel Special Development Zone to attract venture capital for the funding of early stage proof-of-concept clinical trials of new biotech and pharmaceutical products.

IncuBIO holds an exclusive license for the development and commercialization of biotech products, including NeuroEPO, one of the most promising pharmaceuticals from the Center of Molecular Immunology (CIM).

By financing the clinical trials prospective investors will acquire shares in the company and increase product market value.

Cuba’s CIMAB S.A. and Neuronic Mexicana S.A. de C.V. of Mexico are the new partners in the joint venture.

Advertisement. Scroll to continue reading.

CIMAB S.A., was founded in 1992. It is a division of the Center for Molecular Immunology (CIM). The company develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer, cardiology and other autoimmune diseases.

Neuronic Mexicana S.A. was founded in 1996. The company focuses on neuroscience. It is also involved in the development and marketing of biopharmaceutical products and medical equipment.

IncuBIO is now a shareholder in five joint venture companies located in Cuba, China, Thailand, and Singapore.

Related News:

Related News:

Health Care Sector

Vietnam and Cuba have agreed to strengthen ties in the biotechnology sector. Cuba’s Finlay Vaccines Institute and Vietnam’s Vabiotech reached an agreement on November...

Foreign Investment in Cuba

Italy’s Italsav Ltd. announced the company will open a jointly managed shopping center in Havana. Italsav owner Berto Savina said the mall will open...

Events

BioHabana 2022, organized by the Biotechnology, Pharmaceutical, and Medical Technology Industry Group, BioCubaFarma, is scheduled for April 25 to 29. The venue for BioCubaFarma’s...

Health Care Sector

Mexico’s health safety council, the Federal Commission for the Protection against Sanitary Risks (Cofepris) has approved the emergency use of Cuba’s Abdala vaccine. The...

error: This content is copyright protected.